Quimioterapia de elección tras hormonoterapia en cáncer de mama metastásico - page 21

1L CT (HR+HER2-): Active treatments
Anthras re-challenge (liposomal)
Taxanes (or taxane re-challenge)
Capecitabine or vinorelbine; eribulin…
Previous Anthras/taxanes
In patients pretreated with adjuvant taxanes and anthracyclines, other options such
as vinorelbine and capecitabine are also appropriate first-line CT options
[SEOM 2015]
In patients pre-treated (in the adjuvant and/or metastatic setting) with an
anthracycline and a taxane, and who do not need combination CT, single agent
capecitabine, vinorelbine or eribulin are the preferred choices
Additional choices include gemcitabine, platinum agents, taxanes, and liposomal
anthracyclines. The decision should be individualized and take into account different toxicity
profiles, previous exposure, patient preferences, and country availability
[ESMO 2016]
Gavila et al CTO 2015; Cardoso et al Ann Oncol 2016
1...,11,12,13,14,15,16,17,18,19,20 22,23,24,25,26,27,28,29,30,31,...36
Powered by FlippingBook